Literature DB >> 22168491

Human embryonic stem cell therapy in the post-Geron era.

David Brindley, Chris Mason.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22168491     DOI： 10.2217/rme.11.115

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  5 in total

1.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

Authors:  Emma Stephenson; Laureen Jacquet; Cristian Miere; Victoria Wood; Neli Kadeva; Glenda Cornwell; Stefano Codognotto; Yaser Dajani; Peter Braude; Dusko Ilic
Journal:  Nat Protoc       Date:  2012-06-21       Impact factor: 13.491

Review 2.  From bench to FDA to bedside: US regulatory trends for new stem cell therapies.

Authors:  Paul S Knoepfler
Journal:  Adv Drug Deliv Rev       Date:  2014-12-07       Impact factor: 15.470

3.  Strategy for the creation of clinical grade hESC line banks that HLA-match a target population.

Authors:  Laureen Jacquet; Emma Stephenson; Robert Collins; Heema Patel; Jane Trussler; Roaa Al-Bedaery; Pamela Renwick; Caroline Ogilvie; Robert Vaughan; Dusko Ilic
Journal:  EMBO Mol Med       Date:  2012-11-19       Impact factor: 12.137

Review 4.  Magnetic nanoparticles for oligodendrocyte precursor cell transplantation therapies: progress and challenges.

Authors:  Stuart I Jenkins; Humphrey H P Yiu; Matthew J Rosseinsky; Divya M Chari
Journal:  Mol Cell Ther       Date:  2014-07-28

Review 5.  Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.

Authors:  Benjamin M Davies; Sarah Rikabi; Anna French; Rafael Pinedo-Villanueva; Mark E Morrey; Karolina Wartolowska; Andrew Judge; Robert E MacLaren; Anthony Mathur; David J Williams; Ivan Wall; Martin Birchall; Brock Reeve; Anthony Atala; Richard W Barker; Zhanfeng Cui; Dominic Furniss; Kim Bure; Evan Y Snyder; Jeffrey M Karp; Andrew Price; Andrew Carr; David A Brindley
Journal:  J Tissue Eng       Date:  2014-09-19       Impact factor: 7.813
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.